Anupam Rasayan becomes first company to commercialise ETFA, eyes $500 million market

Anupam Rasayan becomes first company to commercialise ETFA, eyes $500 million market


Shares of Anupam Rasayan India Ltd. had opened higher on Friday, June 12, after the speciality chemicals manufacturer announced the commercialisation of ETFA (Ethyl trifluoroacetate) using its proprietary continuous flow chemistry platform. The stock though, has given up all of its initial gains.

The company said it has become the first company globally to manufacture ETFA at a commercial scale using flow technology.

What Is ETFA?

ETFA is a fluorinated chemical intermediate used in the production of a wide range of organic fluorine compounds that find applications across the pharmaceutical, life sciences and performance materials sectors.

Also read: A coffee producer and exporter is the newest purchase made by SBI Mutual Fund; Details here

The product was commercially launched on June 11 and will cater to both domestic and international markets, including the United States and Japan.

According to the company, the global addressable market for ETFA is estimated at $500 million to $600 million.

How Does ETFA Benefit Anupam Rasayan?

Anupam Rasayan said its continuous flow manufacturing process offers advantages over conventional batch production methods, including improved process safety, better scalability, enhanced reproducibility, higher operational efficiency and a lower environmental footprint.

Commenting on the development, Managing Director Anand Desai said the commercialisation of ETFA marks a significant milestone in the company’s innovation journey and demonstrates its capabilities in complex fluorination chemistry and differentiated manufacturing solutions.

The company said it will continue to invest in advanced process technologies, research capabilities and sustainable manufacturing practices as part of its long-term growth strategy.

What Does Anupam Rasayan Do?

Anupam Rasayan operates in custom synthesis and speciality chemicals, serving more than 75 domestic and international customers, including 31 multinational companies. The company manufactures products across life sciences, pharmaceuticals, agrochemicals, personal care, electronics, EV chemicals and polymers.

As of March 2026, the company operated eight manufacturing facilities across India and the United States with a combined installed capacity of about 66,000 metric tonnes.

Shares of Anupam Rasayan made an intraday opening high of ₹1,299 on Friday before cooling off from those levels. The stock now trades 0.2% higher at ₹1,260. The stock is down 7% in the last one month, as a result of which, it has turned negative on a year-to-date basis as well.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *